SonoThera is the world’s first ultrasound-guided gene delivery platform designed to overcome limitations of current gene therapy approaches.
Location: United States
Total raised: $310.75M
Investors 2
| Date | Name | Website |
| 22.09.2024 | Foothill V... | foothill.v... |
| 02.01.2023 | Medical Ex... | medexcelca... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 11.06.2026 | Series B | $125M | Vida Ventu... |
| 10.01.2026 | Series B | $125M | - |
| 05.12.2022 | Series A | $60.75M | - |
Mentions in press and media 10
| Date | Title | Description |
| 16.06.2026 | SonoThera Secures $125M: Ultrasound Reshapes Genetic Medicine | SonoThera, a biotechnology pioneer, just closed a significant Series B funding round. The South San Francisco-based firm secured $125 million. This oversubscribed financing fuels its revolutionary nonviral genetic medicine platform. The inv... |
| 11.06.2026 | SonoThera Raises $125M to Advance Gene Therapy | SonoThera Inc. has secured a $125 million funding round to advance the development of a nonviral, ultrasound-mediated platform for gene therapy. This marked a major change for a significantly evolving industry, focusing on alternative deliv... |
| 10.06.2026 | SonoThera Raises $125M in Series B Funding | SonoThera, a South San Francisco, CA-based biotechnology company developing new genetic medicines, raised $125M in Series B funding. The round was led by Vida Ventures, with participation from ARK Invest, CureDuchenne Ventures, Leaps by Bay... |
| 10.06.2026 | SonoThera Raises $125 Million Series B To Advance Ultrasound-Mediated Genetic Medicines | SonoThera, a biotechnology company developing ultrasound-mediated nonviral genetic medicines, announced the closing of an oversubscribed $125 million Series B financing round to support the clinical advancement of its lead programs for Duch... |
| 10.06.2026 | F2 Raises $14M in Seed Funding | F2, a NYC-based provider of a compounding intelligence platform for private markets, raised $14M in seed funding. The round was led by HighlandX, with participation from existing investors Left Lane Capital, NFX, Y Combinator, and Torch Cap... |
| 10.01.2026 | SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials | SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic m... |
| 17.06.2024 | ISTH 2024 Unveils Late-Breakthrough Abstracts to be Presented in Bangkok, Thailand Showcasing Groundbreaking Science and Research | International scientific meeting convenes in Bangkok, Thailand, for the first time highlighting the important work of the Asian-Pacific scientific and clinical community BANGKOK, June 17, 2024 /PRNewswire/ -- Today, the International Societ... |
| 05.12.2022 | SonoThera Closes $60.75M Series A Funding | SonoThera, a South San Francisco, CA-based biotechnology company, raised $60.75M in Series A funding. The round was led by ARCH Venture Partners, with participation from Illumina Ventures, Johnson & Johnson Innovation, JJDC, Vertex Vent... |
| - | SonoThera | “Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.” |
| - | SonoThera | - |